Keywords: boeh, ing, terminates, ph, iii, metalyse, study

Boeh Ing terminates Ph III Metalyse study

Article | 31 July 2006

Print This

German drugmaker Boehringer Ingelheim says that it has terminated a Phase III study of its developmental drug Metalyse (tenecteplase), under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in